Company Filing History:

5 out of 389

Sanofi-aventis

Years Active: 2002-2011

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7947842 - Hydrates of alkaline-earth salts of irbesartan and the preparation thereof (2011-05-24),

2. 7378521 - Preparation of 2-(2-arylmorpholin-2-yl) ethanol derivatives and intermediates (2008-05-27),

3. 7223860 - Preparation of 2-(2-arylmorpholin-2-yl) ethanol derivatives and intermediates (2007-05-29),

4. 7202267 - Acyloxypyrrolidine derivatives, preparation thereof and application thereof in therapeutic (2007-04-10),

5. 7038044 - Method for preparing 2-(2-arylmorpholin-2-yl)ethanol derivatives and intermediates (2006-05-02),

6. 6465489 - Ureidopiperidine derivatives as selective human NK3 receptor antagonists (2002-10-15),

7. 6392039 - Method for preparing (R)-(+)-3 {1-[2-(4-benzoyl-2(3, 4-difluorophenyl)morpholin-2-yl)ethyl]-4-phenylpiperidin-4-yl}-1,1-dimethylurea, its salts solvates and/or hydrates (2002-05-21),

Title: **Alain Aulombard: Innovator in Pharmaceutical Chemistry**

Introduction

Alain Aulombard, based in Lattes, France, is a noteworthy inventor recognized for his significant contributions to pharmaceutical chemistry. With a portfolio that includes seven patents, Aulombard has made impactful advancements, particularly in the field of drug formulation and preparation.

Latest Patents

Aulombard's most recent patents demonstrate his innovative approach to pharmaceutical composition. One of his latest inventions is related to "Hydrates of alkaline-earth salts of irbesartan and the preparation thereof," which focuses on the creation of hydrates that are pharmaceutically acceptable for use. This invention emphasizes the preparation process in an aqueous medium. Another significant patent involves the "Preparation of 2-(2-arylmorpholin-2-yl) ethanol derivatives and intermediates." This invention outlines a process for creating substituted 2-vinyl-2-arylmorpholine derivatives, along with their intermediates, showcasing his expertise in synthetic organic chemistry.

Career Highlights

Throughout his career, Alain Aulombard has worked with prominent pharmaceutical companies such as Sanofi-Aventis and Sanofi-Synthelabo. His roles in these organizations have enabled him to apply his inventive skills to real-world challenges in drug development and formulation. Aulombard's ongoing pursuit of innovation underscores his commitment to enhancing therapeutic options available in the market.

Collaborations

Alain Aulombard has had the privilege of collaborating with esteemed colleagues, including Sabrina Bonnefoy and Alain Burgos. These collaborations have enriched his work, facilitating the exchange of ideas and fostering an environment conducive to scientific exploration and innovation.

Conclusion

Alain Aulombard's contributions to the field of pharmaceutical chemistry through his patents exemplify his innovative spirit and dedication to improving healthcare solutions. As he continues to contribute to the landscape of drug development, his work stands as an inspiring testament to the power of invention in enhancing human health.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.